Key Metrics
CiteScore 

4.6
Impact Factor 

< 5
Scite Index 

0.87 5-Year SI

SJR 

Q2Pulmonary and Respiratory Medicine

SNIP 

1.15
Recommended pre-submission checks
Powered by 

Topics Covered on ERJ Open Research
ERJ Open Research Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | EUROPEAN RESPIRATORY SOC JOURNALS LTD |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 750 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | European Respiratory Society |
| Frequency | Quarterly |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in ERJ Open Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in ERJ Open Research
Reply: Residual airways: the lingering legacy of severe respiratory syncytial virus bronchiolitis
- 16 Feb 2026
- ERJ Open Research
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trials
- 16 Feb 2026
- ERJ Open Research
Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a post hoc analysis of the ANANKE study
- 16 Feb 2026
- ERJ Open Research
ERJ Open Research in 2026: progress and future directions
- 16 Feb 2026
- ERJ Open Research
Residual airways: the lingering legacy of severe respiratory syncytial virus bronchiolitis
- 16 Feb 2026
- ERJ Open Research
Rectifying COPD management: a critical analysis of the Global Initiative for Chronic Obstructive Lung Disease strategy
- 16 Feb 2026
- ERJ Open Research
Reply: Residual airways: the lingering legacy of severe respiratory syncytial virus bronchiolitis
- 16 Feb 2026
- ERJ Open Research
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trials
- 16 Feb 2026
- ERJ Open Research
Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a post hoc analysis of the ANANKE study
- 16 Feb 2026
- ERJ Open Research
ERJ Open Research in 2026: progress and future directions
- 16 Feb 2026
- ERJ Open Research
Residual airways: the lingering legacy of severe respiratory syncytial virus bronchiolitis
- 16 Feb 2026
- ERJ Open Research
Rectifying COPD management: a critical analysis of the Global Initiative for Chronic Obstructive Lung Disease strategy
- 16 Feb 2026
- ERJ Open Research